Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Soligenix, Inc. - Common Stock
(NQ:
SNGX
)
2.940
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Soligenix, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Unusual volume stocks in Monday's session
August 04, 2025
Unusual volume stocks are being observed in Monday's session.
Via
Chartmill
Traders are paying attention to the gapping stocks in Monday's session.
August 04, 2025
Let's delve into the US markets on Monday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
Via
Chartmill
What's going on in today's session
July 31, 2025
Let's have a look at what is happening on the US markets one hour before the close of the markets on Thursday. Below you can find the top gainers and losers in today's session.
Via
Chartmill
Check out the stocks that are attracting the most attention and driving market activity.
July 31, 2025
Get a pulse on the US markets on Thursday by checking out the most active stocks in today's session. Discover the stocks that are leading the way in terms of trading volume and market activity.
Via
Chartmill
Crude Oil Falls 1%; Meta Earnings Top Views
July 31, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
July 31, 2025
Via
Benzinga
Thursday's session: gap up and gap down stocks
July 31, 2025
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Thursday.
Via
Chartmill
Nasdaq Surges Over 1%; Microsoft Posts Upbeat Earnings
July 31, 2025
Via
Benzinga
Soligenix Drug Matches FDA-Approved Amgen Therapy In Rare Disease Trial
July 31, 2025
Soligenix reports positive Phase 2a trial results for SGX945 in Behçet's disease, showing strong efficacy and no adverse events compared to apremilast.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
July 31, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
July 02, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
July 01, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
July 01, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 24, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 24, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
April 11, 2025
Via
Benzinga
Soligenix Targets Psoriasis With New Therapy
January 17, 2025
Soligenix Targets Psoriasis With New Therapy
Via
News Direct
EXCLUSIVE: Soligenix's Cancer Candidate Shows Encouraging Action With Extended Treatment At One Year
January 14, 2025
Soligenix's IIS study on HyBryte for cutaneous T-cell lymphoma shows 70% success and strong safety profile, with Phase 3 enrollment ongoing.
Via
Benzinga
Soligenix Reports It Is On Cusp Of Treating Rare Cancer CTCL
December 17, 2024
Soligenix Reports It Is On Cusp Of Treating Rare Cancer CTCL
Via
News Direct
EXCLUSIVE: Soligenix Starts Confirmatory Late-Stage Trial For HyBryte For Type Of Blood Cancer
December 16, 2024
Soligenix opens enrollment for the Phase 3 FLASH2 study of HyBryte in early-stage CTCL, aiming to confirm extended treatment efficacy over 18 weeks.
Via
Benzinga
Soligenix, A Pharmaceutical Firm Tackling Potentially Lucrative Unmet Medical Needs
November 27, 2024
Soligenix, A Pharmaceutical Firm Tackling Potentially Lucrative Unmet Medical Needs
Via
News Direct
Soligenix Kickstarts Dusquetide Mid-Stage Study For Patients With Inflamed Blood Vessels
November 14, 2024
Soligenix starts Phase 2 trial of SGX945 for Behçet's Disease, aiming to enroll 25 patients and report results by mid-2025. Trial includes efficacy assessments.
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
November 01, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
October 07, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
October 03, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 03, 2024
Via
Benzinga
Why Levi Strauss Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarket
October 03, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 02, 2024
Via
Benzinga
7 Top Stocks Under $10: July 2024 Edition
July 31, 2024
There are more than 2,100 stocks under $10 from which to choose in the market. If you want to find the best, use the Portfolio Grader.
Via
InvestorPlace
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 10, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.